AbbVie
ABBV
ABBV
2,645 hedge funds and large institutions have $127B invested in AbbVie in 2021 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 1,339 increasing their positions, 872 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,645
Holders Change
-23
Holders Change %
-0.86%
% of All Funds
46.45%
Holding in Top 10
134
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-3.6%
% of All Funds
2.35%
New
116
Increased
1,339
Reduced
872
Closed
97
Calls
$2.19B
Puts
$2.22B
Net Calls
-$32M
Net Calls Change
+$47.7M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$4.73B |
| 2 |
2
BlackRock
New York
|
$13.7B |
| 3 |
3
Goldman Sachs
New York
|
$1.07B |
| 4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$1.13B |
| 5 |
5
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$372M |
